IMOZX
Price
$25.95
Change
-$0.05 (-0.19%)
Updated
Sep 20 closing price
RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

IMOZX vs RPTIX

Header iconIMOZX vs RPTIX Comparison
Open Charts IMOZX vs RPTIXBanner chart's image
Voya MidCap Opportunities R6
Price$25.95
Change-$0.05 (-0.19%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
IMOZX vs RPTIX Comparison Chart
Loading...
VS
IMOZX vs. RPTIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMOZX is a Buy and RPTIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.4B vs. IMOZX (694M). RPTIX pays higher dividends than IMOZX: RPTIX (0.18) vs IMOZX (0.00). IMOZX was incepted earlier than RPTIX: IMOZX (11 years) vs RPTIX (9 years). IMOZX is a more actively managed with annual turnover of: 60.00 vs. RPTIX (21.70). RPTIX has a lower initial minimum investment than IMOZX: RPTIX (500000) vs IMOZX (1000000). IMOZX annual gain was more profitable for investors over the last year : 18.24 vs. RPTIX (14.81). RPTIX return over 5 years is better than : 15.09 vs. IMOZX (6.56).
IMOZXRPTIXIMOZX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years9 years-
Gain YTD6.5149.12771%
Front LoadN/AN/A-
Min. Initial Investment1000000500000200%
Min. Initial Investment IRAN/AN/A-
Net Assets694M31.4B2%
Annual Yield % from dividends0.000.18-
Returns for 1 year18.2414.81123%
Returns for 3 years-22.23-13.57164%
Returns for 5 years6.5615.0943%
Returns for 10 years-2.11N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH246.88-0.54
-0.22%
Clean Harbors
TOI0.29N/A
-0.58%
Oncology Institute (The)
CINT6.59-0.04
-0.60%
CI&T
CSTM16.22-0.54
-3.22%
Constellium SE
KTTA4.43-0.37
-7.71%
Pasithea Therapeutics Corp